{"id":13264,"date":"2015-01-11T10:04:08","date_gmt":"2015-01-11T18:04:08","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/?p=13264"},"modified":"2017-06-04T12:03:03","modified_gmt":"2017-06-04T19:03:03","slug":"tech-giants-quietly-investing-in-synthetic-biology","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2015\/01\/tech-giants-quietly-investing-in-synthetic-biology","title":{"rendered":"Tech giants quietly investing in Synthetic Biology"},"content":{"rendered":"<p>SynBiology<\/p>\n<p><\/p>\n<p>So if I asked what you think will fuel the growth of today\u2019s technology giants in the next 15 years, what would your answer be? You might say familiar or trendy terms, such as user growth or the Internet of Things. Or perhaps that the companies with the most innovative products and services will reign king in tomorrow\u2019s tech markets. And while those are likely partially correct answers, there\u2019s a tremendous amount of growth to be had from a rather unlikely source.<\/p>\n<p>It might be difficult to believe that companies that have traditionally relied on silicon chips, mobile apps, and lines of software code could profit from something as seemingly disconnected as making biological engineering as predictable as traditional engineering fields, but a closer look into research and development spending hints that it may not be that far-fetched after all. Why are <strong>Autodesk (NASDAQ: ADSK)<\/strong> , <strong>Intel (NASDAQ: INTC)<\/strong> , and <strong>Microsoft (NASDAQ: MSFT)<\/strong> quietly investing in synthetic biology, and what could it mean for investors?<\/p>\n<p><a href=\"http:\/\/synbiology.co.uk\/tech-giants-quietly-investing-synthetic-biology\/\" target=\"_blank\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SynBiology So if I asked what you think will fuel the growth of today\u2019s technology giants in the next 15 years, what would your answer be? You might say familiar or trendy terms, such as user growth or the Internet of Things. Or perhaps that the companies with the most innovative products and services will [\u2026]<\/p>\n","protected":false},"author":76,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-13264","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/13264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/76"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=13264"}],"version-history":[{"count":2,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/13264\/revisions"}],"predecessor-version":[{"id":64851,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/13264\/revisions\/64851"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=13264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=13264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=13264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}